Dalia Moawad, Executive Medical Director, Head of Scientific Strategy for Neurology, Ophthalmology, & Internal Medicine US Medical Affairs at Genentech
Advertisement
Articles by Dalia Moawad, Executive Medical Director, Head of Scientific Strategy for Neurology, Ophthalmology, & Internal Medicine US Medical Affairs at Genentech
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Launches Phase 2 TARBELA-AD Trial of NLRP3 Inhibitor in Alzheimer Disease
2
FDA Approves Adrabetadex as First Therapy Shown to Improve Survival in Infantile-Onset Niemann-Pick Disease Type C
3
Spectris Misses Primary End Point in Pivotal HOPE Trial for Alzheimer Disease
4
CTAD 2026 Preview: Clinical Trial Updates and Emerging Alzheimer Disease Research
5
